Rationale Factors associated with long-term sequelae emerging after the acute phase of
COVID-19 (so called “long COVID”) are unclear. Here, we aimed to identify risk factors for …

CONCLUSIONS Interventions that are part of comprehensive pulmonary rehabilitation
approaches may benefit dyspnea and exercise tolerance in adults with COVID-19 and PCC …

Patients with previous CD19-directed chimeric antigen receptor (CAR) T-cell therapy have a
prolonged vulnerability to viral infections. Coronavirus disease 2019 (COVID-19) has a great …

OBJECTIVES: COVID-19 pandemic surges strained hospitals globally. We performed a
systematic review to examine measures of pandemic caseload surge and its impact on …

Treatments for COVID-19 infections have improved dramatically since the beginning of the
pandemic, and glucocorticoids have been a key tool in improving mortality rates. The UK's …

Background While influenza virus and severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) are recognised as a cause of severe illness and mortality, clinical interest for …

Background and objectives: The prognoses of patients experiencing a prolonged stay in the
intensive care unit (ICU) are often significantly altered by hospital-acquired infections (HAIs) …

With the rising numbers of patients infected with severe acute respiratory syndrome
coronavirus 2, long coronavirus disease 2019 (COVID-19)—a sequelae of COVID-19—has …

Background Multiple prolonged symptoms observed in patients who recovered from COVID-
19 are defined as long COVID. Although diverse phenotypic combinations are possible, they …

Background Severe hypoxemia in patients with COVID-19 pneumonia might result from
hypoxic pulmonary vasoconstriction, contributing to ventilation/perfusion (V/Q) mismatch …